A

Ascendia Pharmaceuticals

38 employees

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
amorphous solid dispersions
opthalmic and oral forms
transdermal
formulation of poorly water soluble drugs
Health Care
specialty and pediatric products
injectable
nano-particles
nano-emulsions
immediate or controlled release applications

Date founded

2012

Funding rounds raised

A

Ascendia Pharmaceuticals raised undisclosed on April 8, 2021

Investors: Signet Healthcare Partners

FAQ